GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (LTS:0AAJ) » Definitions » Net Change in Cash

PolyPeptide Group AG (LTS:0AAJ) Net Change in Cash : CHF36.3 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

PolyPeptide Group AG's Net Change in Cash for the six months ended in Jun. 2024 was CHF-45.4 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was CHF36.3 Mil.


PolyPeptide Group AG Net Change in Cash Historical Data

The historical data trend for PolyPeptide Group AG's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Net Change in Cash Chart

PolyPeptide Group AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial 8.16 -0.32 123.94 -97.48 54.87

PolyPeptide Group AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -71.65 -28.53 -27.85 81.79 -45.44

PolyPeptide Group AG Net Change in Cash Calculation

PolyPeptide Group AG's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

PolyPeptide Group AG's Net Change in Cash for the quarter that ended in Jun. 2024


Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF36.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PolyPeptide Group AG Net Change in Cash Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.


PolyPeptide Group AG Business Description

Comparable Companies
Traded in Other Exchanges
Address
Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.

PolyPeptide Group AG Headlines

No Headlines